Cargando…
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
BACKGROUND: We estimated combined protection conferred by prior SARS‐CoV‐2 infection and COVID‐19 vaccination against COVID‐19‐associated acute respiratory illness (ARI). METHODS: During SARS‐CoV‐2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant circulation between October 2021 and April 2022, pro...
Autores principales: | Tartof, Sara Y., Xie, Fagen, Yadav, Ruchi, Wernli, Karen J., Martin, Emily T., Belongia, Edward A., Gaglani, Manjusha, Zimmerman, Richard K., Talbot, H. Keipp, Thornburg, Natalie, Flannery, Brendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209645/ https://www.ncbi.nlm.nih.gov/pubmed/37246146 http://dx.doi.org/10.1111/irv.13143 |
Ejemplares similares
-
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022
por: Sumner, Kelsey M., et al.
Publicado: (2023) -
Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2
por: Chung, Jessie R, et al.
Publicado: (2020) -
988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018) -
2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018
por: Kim, Sara S, et al.
Publicado: (2019) -
Comparative Clinical Evaluation of a Novel FluA/FluB/SARS-CoV-2 Multiplex LAMP and Commercial FluA/FluB/SARS-CoV-2/RSV RT-qPCR Assays
por: Jee, Hyunseul, et al.
Publicado: (2023)